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BACKGROUND & RATIONALE
PICO QUESTION & ELEMENTS
CLINICAL BOTTOM LINESREFERENCES
SEARCH METHODOLOGY
In children ages 4-18, what are the long-term functional 
effects of medulloblastoma treatments?
MAIN FINDINGS & LIMITATIONS
IMPLICATIONS FOR OT PRACTICE
•Increased survival rates due to advances in treatment
•Survivors are at risk for lasting effects that may 
impacteveryday functionalperformance and quality of 
life
•Knowledge of long-term effects could guide client/caregiver 
education and preventative approaches in occupational therapy
Assessment of processing 
speed, working memory, verbal 
skills, executive function, and 
attention is warranted
Monitor cognitive effects of OT 
interventions using a Goal 
Attainment Scale
Radiation associated 
with impaired IQ and 
academic achievement
Better outcomes in 
cognitive 
functioning
associated 
with age, dosage, time 
of diagnosis, and 
medulloblastoma type
Generalized or 
separation anxiety 
common
Databases:
•Scopus,Cochrane Library,CINAHL, PubM
ed, Ovid M
EDLINE
Inclusion Criteria
•Adult medulloblastoma survivors who received treatmentbetween the ages 4-
18
•Focused on functional effects and/or quality of life
•Explored effects that may connect to functional performance
Exclusion Criteria
•Clients developed secondary disease(s) as a result of thediagnosis and/or 
treatment received
•Published more than ten years ago
•Single case studies
PICO QUESTION
EXAMPLE SEARCH TERMS USED
Population:
Children ages 4-18 years old
Child, youth, adolescent, teen, 
preschool, medulloblastoma
Intervention:
Medulloblastoma treatment
Treatment, radiation, surgery, 
chemotherapy, tumor resection, 
procedure, medication, therapy
Outcome:
Functional deficits
Outcome, effect, consequence, 
result, product, reaction, functional
LEVEL OF 
EVIDENCE
STUDY AND 
QUALITY SCORE
M
AIN FINDINGS
LIM
ITATIONS
II
•
M
oxon-Emre 
et al., 2016 
Quality 
Score: 77%
•
Limiting radiation exposure 
produces ↑
intellectual 
outcomes(M
oxon-Emre et al., 2016; 
Szenteset al., 2018)
•
љ
in processing speed, attention, 
working memory, and verbal 
skills(M
oxon-Emre et al., 2016; 
Szenteset al., 2018)
•
↑
 in generalized and separation 
anxiety
(Szenteset al., 2018)
•
Small sample
•
Brinkman et 
al.,2016 
Quality Score: 
77%
•
Szenteset al., 
2018 Quality 
Score: 95%
III
•
Edelstein et 
al., 
2011Quality 
Score: 77%
•
љ
in working memory regardless of 
age of treatment
•
Cognitive and physical signs of early 
aging regardless of age of diagnosis
•
Younger age of diagnosis associated 
with a љ
in IQ and academic scores
•
Small sample
•
Retrospective 
study
•
Only focuses on 
radiation 
treatment
IV
•
Kennedy et al., 
2014 Quality 
Score: 86%
•
љ
in cognition (e.g., executive 
function, attention capacity, 
processing speed)
•
Not in the US
•
No true control
•
Saury 
&
Emanuelson
, 2010 Quality 
Score: 90%
W
HAT IS MEDULLOBLASTOMA?
Most common 
primary 
malignant CNS 
braintumor in 
children
Usually appears 
as a solid mass in 
thecerebellum 
between the 
brain and brain 
stem
Classified by 4 
subgroups: W
N
T, SHH,Group 
3,Group 4
Survival rates 
are around 60-
80%
Long-Term Functional Effects of Medulloblastoma Treatments
GOAL ATTAINMENT SCALE
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The final portfolio contains 6 research articles from both national and international journals. Study designs include two 
cohort studies with a control group, 1 cross sectional study with a control group, 1 retrospective cohort study without a 
control group, 1 descriptive report on a Randomized Control Trial (RCT), and 1 descriptive study. All studies relate 
directly to components of the evidence-based practice question and will be used to understand possible effects of 
radiation treatment for clients diagnosed with medulloblastoma cancer.  All articles describe clients showing signs of 
decreased cognition after treatment. This theme, as well as others, will be discussed in detail.  
 
Focused Question 
In children ages 4-18, what are the long-term functional effects from medulloblastoma treatments? 
Clinical Scenario 
With the development of medulloblastoma treatment over time, survival rates have increased. However, due to the harsh nature 
of these treatments, survivors are at risk for lasting effects. We chose the age range of 4-18 because treatment is significantly 
different in children younger than 4 compared to children older than 4 years old. Effects include cognitive, emotional, and 
physical deficits that may potentially impact every day, functional performance and quality of life.  
Search Methodology and Terms  
Databases and Sources 
Searched 
Search Terms Limits Used 
Ovid, Scopus, Cochrane 
Library, CINAHL, 
PubMed, Medline  
(Child OR children OR “Child”[Mesh] OR 
“Adolescent”[Mesh] OR teen*) AND 
"medulloblastoma" AND functional AND 
(“Therapeutics/radiation effects”[Mesh] OR 
“Therapeutics/surgery”[Mesh] OR 
“Therapeutics/therapy”[Mesh] OR radiation OR 
medicine OR medication OR chemotherapy OR 
tumor resection OR surgery OR procedure) AND 
(“Treatment Outcome”[Mesh] OR outcome OR 
consequence OR effect OR result OR reaction OR 
product) 
• Within last 10 years  
• English 
• Full text 
  
Inclusion Criteria for Articles 
• Adult medulloblastoma survivors who received treatment between the ages 4-18 
• Focused on functional effects and/or quality of life were  
• Articles that explored effects that may connect to functional performance (e.g., executive function, processing speed, 
working memory) 
Exclusion Criteria for Articles 
• Clients developed secondary disease(s) as a result of the diagnosis and/or treatment received  
• Published more than ten years ago  
• Single case studies  
Review Process 
• Large number of cases of medulloblastoma due to new treatments/increased survival rates and not enough information on 
long term-effect 
• Among search results, articles were included or excluded depending on relevancy of abstract or full text to the PICO question 
• Each group member chose 1-2 articles to critically appraise using critical appraisal forms developed by Law & McDermid, 
2014. 
• Meetings with a mentor and professor, as well as between group members, ensured quality control throughout this process 
Search Results by Level of Evidence 
Study Design Level Number Located Author (Year) 
• 2 Cohort with control 
group 
• Cross Sectional with 
control 
II 3 • Moxon-Emre et al., (2016); 
Brinkman et al., (2016) 
• Szentes et al., (2018) 
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• Retrospective cohort 
study without a 
control group 
III 1 • Edelstein et al., (2011) 
• Descriptive report on 
RCT 
• Descriptive study 
IV 2 • Kennedy, et al., (2014) 
• Saury & Emanuelson (2010) 
TOTAL ARTICLES REVIEWED: 6 
Main Findings 
Level of Evidence  Quality Score  Main Findings and Limitations 
II • 77% (Moxon-Emre et al., 
2016) 
• 77% (Brinkman et al., 2016) 
• 95% (Szentes et al., 2018) 
Main Findings: 
• Limiting radiation exposure produces favorable intellectual 
outcomes. (Moxon-Emre et al., 2016; Szentes et al., 2018) 
• Children with medulloblastoma experience anxiety significantly 
more than a control group. (Brinkman et al., 2016; Szentes et al., 
2018) 
• Children with medulloblastoma experienced a decrease in 
processing speed, attention and working memory, and verbal 
skills. (Moxon-Emre et al., 2016; Szentes et al., 2018) 
Limitations:  
• Small sample (Moxon-Emre et al., 2016; Szentes et al., 2018) 
III • 77% (Edelstein et al., 2011) 
 
Main Findings: 
• Adults who had childhood medulloblastoma may have a decline 
in working memory due to radiation treatment regardless of age 
of treatment 
• Cognitive and physical signs of early aging regardless of age of 
diagnosis 
• Younger age of diagnosis was associated with a decline in IQ 
and academic scores 
Limitations: 
• Small sample 
• Retrospective study 
• Only focuses on radiation treatment  
IV • 86% (Kennedy et al., 2014) 
• 90% (Saury & Emanuelson, 
2010) 
 
Main Findings: 
• Decrease in cognition (e.g., executive function, attention 
capacity, processing speed) (Kennedy et al., 2014; Saury & 
Emanuelson, 2010). 
Limitations:  
• Not in the United States (Kennedy et al., 2014; Saury & 
Emanuelson, 2010) 
• No true control 
Bottom Lines and Recommendations 
Weaknesses 
• Majority have small sample sizes  
• 3 were not in the U.S. 
• 3 articles did not have a control 
• No level one evidence due to the descriptive nature of the PICO question 
Contradictions 
• The retrospective cohort study states that younger age of diagnosis is associated with decline in IQ and academic scores. 
However, a higher level of evidence states that age does not play a factor. 
• This may be due to articles looking at different factors and having different limitations and levels of evidence 
Clinical Bottom Lines and Recommendations 
• Radiation is associated with impaired IQ and academic achievement 
• Better outcomes in cognitive functioning are associated with age, dosage, time of diagnosis, and medulloblastoma type 
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• Generalized or separation anxiety found to be common 
• Assessment of processing speed, working memory, verbal skills, executive function, and attention is warranted 
• Monitor cognitive effects of occupational therapy interventions using a Goal Attainment Scale 
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Appendix A 
 
Critically Appraised Papers (CAPs) and Quality Report Forms 
 
Critically Appraised Paper #1 
 CAP completed by Serena Khiantani 
 
Edelstein, K., Spiegler, B. J., Fung, S., Panzarella, T., Mabbott, D. J., Jewitt, N., … Hodgson, D. C. (2011). Early aging in  
     adult survivors of childhood medulloblastoma: Long-term neurocognitive, functional, and physical outcomes. 
     Neuro-Oncology, 13(5), 536–545. doi:10.1093/neuonc/nor015 
Purpose of the Study To retrospectively examine the “long-term outcomes in adult survivors of childhood 
medulloblastoma, providing a cross-sectional analysis of current neurocognitive, functional, and 
physical status” (Edelstein, et al., 2011, p.537). This study matches our population and 
specifically looks at the long-term functional effects from medulloblastoma treatments, such as 
CSI treatments. 
Setting Princess Margaret Hospital; long-term follow up care-Outpatient clinic 
Participants or Sample • 20 adults who were treated with surgery and radiotherapy for medulloblastoma during 
childhood; nine patients also underwent chemotherapy 
• 14 males; 6 females 
• median age at assessment, 21.9 years [range, 18 – 47 years]; median time since diagnosis, 15.5 
years [range, 6.5–42.2 years] 
• 4 participants were diagnosed with medulloblastoma before the age of four. 
• During the period from 2005 through 2009, 
• 90% had required accommodations at school for learning disorders 
• Sample chosen: Adult survivors of childhood medulloblastoma routinely undergo 
comprehensive neuropsychological assessments as part of their long-term follow- up care at 
Princess Margaret Hospital, 
• Convenience Sampling “sample size is based on all available cases of the study time frame” 
(Edelstein, et al., 2011, p.537). 
Study Design and 
Methodology 
Retrospective Cohort Study. The researchers retrospectively analyzed data from follow-up 
neuropsychological assessments and medical charts and looked at the neurocognitive, physical, 
and functional outcomes for adults treated for medulloblastoma in childhood. 
Level of Evidence Level III 
Outcomes and Main Findings • Longer time since diagnosis was associated with a continued decline in working memory, 
regardless of age-statistically significant 
• Younger age of diagnosis was associated with a decline in IQ and academic scores - 
statistically significant 
• Longer time since diagnosis is associated with decline in academic achievement- not 
statistically significant. The article compares this to a different research study that found similar 
results–academic achievement declined the first 5-10 years after diagnosis but then plateaued. 
• Scores from the sample of medulloblastoma survivors in adulthood after treatment were lower 
than the population norms for VIQ, working memory, speed, academic achievement, executive 
function, memory, and motor dexterity -statistically significant 
• Specifically, the data shows the possibility that adults who had childhood medulloblastoma 
may have a decline in working memory due to radiation treatment regardless of age of treatment. 
• All participants developed health complications after completing their treatment. This included 
hearing impairment, second cancers, diabetes, hypertension, and endocrine deficiencies. These 
are deficits other articles have noted as possible causes of radiation treatment. 
• Scores from sample the medulloblastoma survivors in adulthood after treatment were lower 
than population norms for PIQ-not statistically significant 
• Outcome measures: Table 2 has 41 assessments including those that test verbal skills, 
perceptual skills, working memory, speed, academic achievement, executive function, memory, 
and motor dexterity 
• According to the study, the assessments are “validated, objective measures” (Edelstein, et al., 
2011, p.540), However, there were inconsistencies for which test or version of test was used for 
each participant, so they chose domains where analogous measures were used. 
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Intervention Highlighted 
Through the Research 
Childhood medulloblastoma is the most common form of childhood cancer. However, 
there is not enough data to understand the long-term outcomes in adult survivors of 
childhood medulloblastoma. 
Limitations • Small sample size 
• Retrospective study design -rely on others for data 
• Doesn’t state if there were different people conducting the assessments 
• Differences in number of assessments, test administered, and timing of tests 
• Possible selection bias due to convenience sample 
• The researchers were not able to see the possible initial decline in performance because data 
was collected 10 years after treatment 
• Doesn’t consider other types of treatment other than radiation that could affect function, such as 
surgical treatments and chemotherapy 
This Study Was Identified as 
the “Best” Evidence and 
Selected for the Portfolio for 
the Following Reasons: 
• Compares the participant’s neurocognitive, functional, physical status with previous research in 
order to understand which functional deficits could possibly be caused by radiation treatment. 
•Written within the last ten years and is considered to be high quality evidence 
• Looks at other variables that may contribute to the decline of function, such as time of 
diagnosis and age of diagnosis (see outcomes and main findings for specifics) 
• Very detailed in presenting the patients’ information, treatment received, age and time of 
diagnosis, and functional performance. 
• Helps us understand the many factors involved in the decline of function for adult survivors of 
childhood medulloblastoma. This helps us understand that the long-term outcomes can vary 
based on age and time of diagnosis as well as understand the possible effects of radiation 
treatment over time. 
Quality Score: 77% 
 
Checklist for Assessing Technical Quality of 
Quantitative Descriptive Studies 
(Yes = 1, No = 0) 
1. Study Design 
Criterion 1.1: Is the study design clear and appropriate 
for addressing the research questions?  
1 
Criterion 1.2: Are the program(s) or conditions applying 
to the group(s) of interest clearly described in sufficient 
detail to understand and replicate?  
1 
Criterion 1.3: Are key features of the design—including 
time, place, and context clearly described? This includes 
the sampling design, if applicable.  
1    
Criterion 1.4: Does the study explain limitations of the 
design and draw appropriate implications for interpreting 
findings?  
1 
2. Data Quality  
Criterion 2.1: Are data sources clearly identified and 
appropriate for addressing the research questions?  
0 
Criterion 2.2: Do key variables and/or outcome measures 
have face validity and does the study discuss their 
reliability and validity?  
0 
Criterion 2.3: Are issues of data completeness, 
consistency, and accuracy, as well as steps researchers 
took to resolve these issues, addressed clearly, in 
sufficient detail, and appropriately?  
1 
Criterion 2.4: Is the description of study-designed 
variables clear and do study-designed variables make 
sense given the outcome of interest for the research 
question? 
 
 
1 
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3. Data Collection  
Criterion 3.1: Are the data collection methods, sources, 
and instruments clearly described and appropriate for the 
research questions?  
1 
Criterion 3.2: Does data collection reflect sound and 
systematic methods to produce reliable data?  
0  
Criterion 3.3: Does data collection reflect methods that 
produce unbiased results?  
 
0  
4. Study Sample  
Criterion 4.1: Does the study examine a population 
relevant to the research questions?  
1 
Criterion 4.2: Is the sampling design clearly defined and 
defensible?  
1 
Criterion 4.3: Are inclusion and/or exclusion restrictions 
clear and defensible?  
0 
Criterion 4.4: Is the analytic sample appropriate and 
described clearly and in adequate detail?  
1 
Criterion 4.5: Does the study discuss limitations of the 
sample and/or sampling procedure? 
1 
5. Analysis Methods 
Criterion 5.1: Are the analysis methods clearly 
described, appropriate for the research questions, 
sufficiently rigorous, and correctly executed? 
1 
Criterion 5.2: Does the report clearly explain and justify 
key analysis decisions?  
1 
Criterion 5.3: Are appropriate statistical procedures 
used?  
1 
Criterion 5.4: Are limitations of the analytic methods 
discussed, especially those that could lead to bias?  
1 
6. Findings and Conclusions  
Criterion 6.1: Are findings fully supported by the data 
and analysis?  
1 
Criterion 6.2: Are conclusions supported by the 
findings?  
1 
Quality score: 77% 
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Critically Appraised Paper #2 
CAP completed by Pamela Ponce 
 
Kennedy, C., Bull, K., Chevignard, M., Culliford, D., Dörr, H. G., Doz, F., … Calaminus, G. (2014). Quality of survival and 
growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional 
radiation therapy for standard-risk medulloblastoma. International Journal of Radiation Oncology*Biology*Physics, 
88(2), 292–300. doi: 10.1016/j.ijrobp.2013.09.046 
Purpose of the Study • “To compare quality of survival in ‘standard-risk’ medulloblastoma after hyperfractionated 
radiation therapy [(HFRT)] of the central nervous system with that after standard radiation 
therapy, combined with a chemotherapy regimen common to both treatment arms, in the 
PNET4 randomized controlled trial” (Kennedy, et al., 2014, p.292). 
• This study addresses a broad range within our targeted population in our PICO question (i.e., 
childhood medulloblastoma survivors). Although the purpose of the study is to compare the 
effects of two different forms of radiation treatment, it provides information on potentially 
functional effects of both forms of treatment. 
Setting • Setting of RCT (i.e., PNET4) is unspecified 
• Data gathered from standardized assessments were from seven anonymized countries in 
Europe 
Participants or Sample • N = 151 
• Dx 
o Medulloblastoma 
• Criteria 
o Diagnosed with medulloblastoma 
o Aged 4-21 years 
o Participated in PNET4 
• Sampling method 
o Non-probability purposive sampling 
• Mean age = 15.2 years 
• Number of males and females are unspecified 
• Comorbidities/Covariates – “Sensitivity analyses were used to examine possible confounding 
by baseline characteristics” (p.294). 
Study Design and 
Methodology 
• Descriptive study of RCT 
“… report on quality of survival in the PNET4 RCT” 
• The PNET4 was conducted between 2002-2006. Survivors in remission during the 2010-2011 
9-month cross-sectional follow-up 
Level of Evidence • Level IV 
Outcomes and Main Findings • “Scores in subgroups… showed no statistically significant differences between treatment arms 
other than lower (better) adult self-report BRIEF executive function scores in those aged >18 
years at assessment” (p.294). 
o Secondary outcomes include hormone replacement, therapy services, hearing aids, state 
benefits, and cosmetic outcome 
• “In a sensitivity analysis, exclusion of the 6 participants with premorbid developmental 
impairment did not materially alter the effect size of treatment allocation on executive 
function” (p.295). 
• QoS measures – all outcomes (listed below) in the HFRT group were higher than the STRT 
group. Executive function is the only outcome with a significant difference in mean between 
the two groups. Although the scores in the STRT group were lower than the HFRT group, all 
relevant mean z-score outcomes were within 1 SD of the mean and may be considered within 
normal limits. 
o Executive function (BRIEF-GEC) 
o Health status (HUI3) 
o Behavioral difficulties (SDQ) 
o Quality of life 
Intervention Highlighted 
Through the Research 
• PNET4 which was comprised of… 
o Hyperfractionated radiation therapy (HFRT) 
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o “…was given in 68 fractions: 1.0 Gy twice per day with an 8-hour interval 
between fractions, given over 48 days” (p.293). 
o Conventionally fractioned standard treatment (STRT) 
o “…comprised 23.4 Gy to the craniospinal axis and 54 Gy to the posterior fossa 
and was given over 42 days in 30 daily fractions of 1.8 Gy for 5 days per week” 
(p.293). 
• 244 survivors who participated in PNET4, in addition to their caregiver(s)/parent(s), completed 
standardized questionnaires on executive function, health status, behavior, and health-related 
quality of life. Medical, educational, employment, and social information was also recorded. 
Limitations • Only used BRIEF as a measurement for EF 
• The RCT only focused on the comparison between two treatment groups and did not provide a 
control. 
• Potentially subjective self-reports on questionnaires 
This Study Was Identified as 
the “Best” Evidence and 
Selected for the Portfolio for 
the Following Reasons: 
• Compares the effects of two types of medulloblastoma treatment in children and young adults 
on health-related quality of life, executive function, health status and behavioral difficulties – 
all of which are functional components of daily living. It also briefly provides information on 
and compares premorbid developmental impairment and postoperative neurological outcomes. 
between participants and non-participants. 
Quality Score: 86% 
 
1. Study Design 
 
 
Criterion 1.1: Is the study design clear and appropriate for addressing the research 
questions? 
1 
Criterion 1.2: Are the program(s) or conditions applying to the group(s) of interest 
clearly described in sufficient detail to understand and replicate? 
1 
Criterion 1.3: Are key features of the design—including time, place, and context 
clearly described? This includes the sampling design, if applicable.  
- Apart from reporting that the data gathered from questionnaires came from 7 
anonymous countries, there was no further description of where the PNET4 took 
place or where, specifically, in Europe recruitment was done for the PNET4 RCT. 
0 
Criterion 1.4: Does the study explain limitations of the design and draw 
appropriate implications for interpreting findings? 
1 
2. Data Quality 
 
 
Criterion 2.1: Are data sources clearly identified and appropriate for addressing the 
research questions? 
1 
Criterion 2.2: Do key variables and/or outcome measures have face validity and 
does the study discuss their reliability and validity? 
- With the exception of the BRIEF questionnaire, psychometric properties of 
outcome measures were not discussed. 
0 
Criterion 2.3: Are issues of data completeness, consistency, and accuracy, as well 
as steps researchers took to resolve these issues, addressed clearly, in sufficient 
detail, and appropriately? 
- Ran a variety of sensitivity tests in order to account for any potential confounding 
factors (e.g., exclusion of 6 participants, baseline characteristics) 
1 
Criterion 2.4: Is the description of study-designed variables clear and do study-
designed variables make sense given the outcome of interest for the research 
question? 
1 
3. Data Collection  
Criterion 3.1: Are the data collection methods, sources, and instruments clearly 
described and appropriate for the research questions? 
1 
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Criterion 3.2: Does data collection reflect sound and systematic methods to 
produce reliable data? 
 
 
 
1 
Criterion 3.3: Does data collection reflect methods that produce unbiased results? 
- Evidence of independence and objectivity of the research team not explicitly 
reported 
 
1 
4. Study Sample  
Criterion 4.1: Does the study examine a population relevant to the research 
questions? 
1 
Criterion 4.2: Is the sampling design clearly defined and defensible? 
- Indication of whether sample is purpose or non-purposive is not explicitly stated 
but this is information that can be gathered from the reader 
- Does not discuss generalizability to wider population 
1 
Criterion 4.3: Are inclusion and/or exclusion restrictions clear and defensible? 1 
Criterion 4.4: Is the analytic sample appropriate and described clearly and in 
adequate detail? 
- Does not rationalize sample size, however, for the purposes of this study, the 
researchers did not have a choice but to collect data from those who survived and 
were in remission from the PNET4. 
1 
Criterion 4.5: Does the study discuss limitations of the sample and/or sampling 
procedure? 
0 
5. Analysis Methods  
Criterion 5.1: Are the analysis methods clearly described, appropriate for the 
research questions, sufficiently rigorous, and correctly executed? 
1 
Criterion 5.2: Does the report clearly explain and justify key analysis decisions? 1 
Criterion 5.3: Are appropriate statistical procedures used? 1 
Criterion 5.4: Are limitations of the analytic methods discussed, especially those 
that could lead to bias? 
- Accounted for confounding factors, etc. via sensitivity tests and discussed results 
- Does not report limitations 
1 
6. Findings and Conclusions  
Criterion 6.1: Are findings fully supported by the data and analysis? 1 
Criterion 6.2: Are conclusions supported by the findings? 1 
Quality score: 86% 
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Critically Appraised Paper #3 
CAP completed by Sarika Maymoundok 
 
Saury, J. M., Emanuelson, I. (2010). Cognitive consequences of the treatment of medulloblastoma among children. Pediatric 
Neurology, 44(1), 21-30. https://doi.org/10.1016/j.pediatrneurol.2010.07.004 
Purpose of the Study  • Study how various medulloblastoma treatments affect cognition in children 
• Aspects of cognition include: IQ, verbal ability, perceptual reasoning skills, processing speed, 
attention, and working memory.  
Setting  • Swedish rehabilitation facility  
Participants or Sample  • 8 children diagnosed with medulloblastoma 
• Treated at the rehabilitation facility  
• Age range of participants 4-11 years 
• All children were treated with radiation and chemotherapy.  
Study Design and 
Methodology  
• Assessed with the Wechsler Intelligence Scale for Children as a part of the formal assessment 
and follow up 
• First one was 2.9 years after diagnosis 
• Follow-up tested 5.1 years after diagnosis 
Level of Evidence  Level IV  
Outcomes and Main Findings  • “Results of the first assessment suggest (1) that, at the time of the initial assessment, our 
subjects already exhibited significant cognitive deficits in the more impaired range, especially 
in their perceptual reasoning skills, their attention capacity, and their processing speed; and (2) 
that their abstract verbal capacity was relatively preserved compared with the other measures” 
(Saury & Emmanuelson, 2010).  
• “The results during follow-up 5 years after diagnosis were characterized by (1) a decrease in 
ability to a level about 2 standard deviations below the mean for all intelligence quotients and 
factors, except for freedom from distractibility; (2) a specific decrease in perceptual reasoning 
skills to a very low level; (3) a relatively higher level of attention capacity, as expressed by the 
freedom from distractibility factor; and (4) a lack of decrease in the processing speed factor to 
that of the three intelligence quotients” (Saury & Emmanuelson, 2010).  
• “The patients demonstrated a significantly lower rate of acquisition of psychomotor skills, as 
measured by the coding subtest. This finding suggests that our patients experienced difficulties 
with tasks demanding fine-motor ability, such as writing. These difficulties, in turn, exert an 
impact on school performance, and lead to increased risk for academic failure” (Saury & 
Emmanuelson, 2010).  
• “Able to delineate three parameters that may have contributed to the low performance of our 
patients in measures of verbal comprehension, perceptual organization, social cognition, and 
psychomotor skills: (1) high intracranial pressure, (2) high levels of radiation, and Zcx (3) 
limited support for school reintegration” (Saury & Emmanuelson, 2010).  
 
Intervention Highlighted 
Through the Research  
• Not an intervention study 
• Researchers looked at how medulloblastoma treatments affected cognitive skills in patients 
ages 4-11 years 
Limitations  Limitations included:  
• Low number of patients because of the rarity of medulloblastoma in Sweden 
• Lack of a control group 
• Lack of reliable information on radiation doses and sites 
• Lack of background information on earlier school achievements of the patients 
• Inferences had to be made from the data collected to functional implications to answer the 
PICO question.  
This Study Was Identified as 
the “Best” Evidence and 
Selected for the Portfolio for 
the Following Reasons: 
• This study looked at cognitive skills and reasoning in children after medulloblastoma 
treatment and many functional school- related activities are tied to the cognitive skills such as 
fine motor ability and the impact it has on school performance. It also was a longitudinal study 
as it assessed the patients 3 and 5 years after diagnosis/treatment, which is applicable to the 
PICO question.  
Quality Score: 90% 
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1. Study Design 
 
 
Criterion 1.1: Is the study design clear and appropriate for addressing the research 
questions? 
1 
Criterion 1.2: Are the program(s) or conditions applying to the group(s) of interest 
clearly described in sufficient detail to understand and replicate? 
1 
Criterion 1.3: Are key features of the design—including time, place, and context 
clearly described? This includes the sampling design, if applicable.  
 
1 
Criterion 1.4: Does the study explain limitations of the design and draw 
appropriate implications for interpreting findings? 
1 
2. Data Quality 
 
 
Criterion 2.1: Are data sources clearly identified and appropriate for addressing the 
research questions? 
1 
Criterion 2.2: Do key variables and/or outcome measures have face validity and 
does the study discuss their reliability and validity? 
 
1 
Criterion 2.3: Are issues of data completeness, consistency, and accuracy, as well 
as steps researchers took to resolve these issues, addressed clearly, in sufficient 
detail, and appropriately? 
 
0 
Criterion 2.4: Is the description of study-designed variables clear and do study-
designed variables make sense given the outcome of interest for the research 
question? 
1 
3. Data Collection  
Criterion 3.1: Are the data collection methods, sources, and instruments clearly 
described and appropriate for the research questions? 
1 
Criterion 3.2: Does data collection reflect sound and systematic methods to 
produce reliable data? 
0 
Criterion 3.3: Does data collection reflect methods that produce unbiased results? 1 
4. Study Sample  
Criterion 4.1: Does the study examine a population relevant to the research 
questions? 
1 
Criterion 4.2: Is the sampling design clearly defined and defensible? 1 
Criterion 4.3: Are inclusion and/or exclusion restrictions clear and defensible? 1 
Criterion 4.4: Is the analytic sample appropriate and described clearly and in 
adequate detail? 
1 
Criterion 4.5: Does the study discuss limitations of the sample and/or sampling 
procedure? 
1 
5. Analysis Methods  
Criterion 5.1: Are the analysis methods clearly described, appropriate for the 
research questions, sufficiently rigorous, and correctly executed? 
1 
Criterion 5.2: Does the report clearly explain and justify key analysis decisions? 1 
Criterion 5.3: Are appropriate statistical procedures used? 1 
Criterion 5.4: Are limitations of the analytic methods discussed, especially those 
that could lead to bias? 
1 
6. Findings and Conclusions  
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Criterion 6.1: Are findings fully supported by the data and analysis? 1 
Criterion 6.2: Are conclusions supported by the findings? 1 
Quality score: 90% 
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Critically Appraised Paper #4 
CAP completed by Bailey Diprima 
 
Szentes, A., Eros, N., Kekecs, Z., Jakab, Z., Torok, S., Schuler, D., Hauser, P., & Garami, M. (2018). Cognitive deficits and 
psychopathological symptoms among children with medulloblastoma. European Journal of Cancer Care, 27(6). 
https://doi.org/10.1111/ecc.12912 
Purpose of the Study • The purpose of this study is to examine the cognitive functioning of Medulloblastoma 
survivors and identify factors associated with these cognitive impairments. The factors that are 
considered in this study are age of treatment, gender, time since diagnosis, and radiation dose.  
• It also examines the psychopathological risks that medulloblastoma survivors are likely to 
experience like major depression, post- traumatic stress disorder, and anxiety disorders. 
Setting • The testing procedures for the study group were taking during a follow up medical visit in 
the clinic.  
• The control group was tested in a quiet classroom in the children’s primary or secondary 
grammar school. 
Participants or Sample • 34 children who were previously treated for medulloblastoma were in the study group, 65% 
male and 35% female. Their ages were 6-16. 46 children were recruited from a primary and 
secondary grammar school, 50% male and 50% female. Their ages 7-16. Their inclusion 
criteria included no history of any chronic illnesses and not having a diagnosis of any learning 
disorder. 
Study Design and Methodology • This cross-sectional study provides a comprehensive examination of the cognitive and 
psychopathological functioning among a group of survivors of medulloblastoma. All children 
were given an age appropriate Hungarian version of the Wechsler Intelligence Scale for 
children and the Mini International Neuropsychiatric interview for children and adolescents. 
 
Level of Evidence  
 
Level II 
Outcomes and Main Findings 
 
• Age and gender did not significantly differ between the two groups. The FSIQ and WISC 
(measuring cognitive functioning) subscale of the MB patients were statistically significantly 
lower than the population mean. This included verbal comprehension index, perceptual 
reasoning index, working memory index, and processing speed index. A post hoc analyses 
showed that verbal comprehension was significantly higher than perceptual reasoning and 
processing speed but not working memory. 
• Of the five independent variables, high radiation dose and high dose chemotherapy with stem 
cell rescue were significantly associated with lower IQ. Age, gender, and time period of 
diagnosis held no significant value. 
• The MINI international neuropsychiatric interview showed that children who have had 
medulloblastoma had significantly more children suffering from separation anxiety, 
compulsive disorder, post-traumatic stress, and generalized anxiety compared to the control 
group. 
• There was no relationship between occurrence of psychopathological symptoms and IQ. 
• In conclusion, children with MB show impaired intelligence in both global IQ and 
subdomains of functioning. Verbal skills seemed to be less affected than processing speed, 
attention and working memory. High radiation dose and stem cell are significantly associated 
with factors that lower global IQ. Age, gender, and time of diagnosis have no significant factor 
associated with post treatment intelligence. 
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Intervention Highlighted 
Through the Research 
 
 
• This study is interested in looking at the cognitive and psychopathological symptoms that 
can occur after treatment of medulloblastoma. 
• Some clinical implications that were highlighted in this study include early cognitive 
rehabilitation programs for children who experienced delays. Routine checks on psychological 
and cognitive status could help drive therapeutic interventions and prevention of increased 
symptoms. 
Limitations 
 
• One limitation of the study was the assessment of the separation anxiety. Researchers feel 
that since the children were assessed in the hospital negative memories and emotions could 
have been triggered from their past separation experiences.  
• Another limitation highlighted was the small sample size. It did not allow for great detail 
therefore decreased generalizability. The cross- sectional design prevents from drawing any 
direct causal inference between medulloblastoma and IQ impairments. It also forbids the 
inference of progression of cognitive deficits over time. 
This Study Was Identified as 
the “Best” Evidence and 
Selected for the Portfolio for the 
Following Reasons: 
• This was considered best evidence due to it answering our PICO question. This article 
highlights functional deficits that can be associated with individuals who have experienced 
medulloblastoma. 
Quality Score: 95% 
 
1. Study Design  
Criterion 1.1: Is the study design clear and appropriate for addressing the research 
questions? 
1 
Criterion 1.2: Are the program(s) or conditions applying to the group(s) of interest 
clearly described in sufficient detail to understand and replicate? 
1 
Criterion 1.3: Are key features of the design—including time, place, and context 
clearly described? This includes the sampling design, if applicable.  
1 
Criterion 1.4: Does the study explain limitations of the design and draw 
appropriate implications for interpreting findings? 
1 
2. Data Quality  
Criterion 2.1: Are data sources clearly identified and appropriate for addressing the 
research questions? 
1 
 Criterion 2.2: Do key variables and/or outcome measures have face validity and  
 does the study discuss their reliability and validity? 
1 
 Criterion 2.3: Are issues of data completeness, consistency, and accuracy, as well 
as steps researchers took to resolve these issues, addressed clearly, in sufficient 
detail, and appropriately? 
1 
Criterion 2.4: Is the description of study-designed variables clear and do study-
designed variables make sense given the outcome of interest for the research 
question? 
1 
3. Data Collection  
Criterion 3.1: Are the data collection methods, sources, and instruments clearly 
described and appropriate for the research questions? 
1 
Criterion 3.2: Does data collection reflect sound and systematic methods to 
produce reliable data? 
1 
Criterion 3.3: Does data collection reflect methods that produce unbiased results? 1 
4. Study Sample  
Criterion 4.1: Does the study examine a population relevant to the research 
questions? 
1 
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Criterion 4.2: Is the sampling design clearly defined and defensible? 1 
Criterion 4.3: Are inclusion and/or exclusion restrictions clear and defensible? 1 
Criterion 4.4: Is the analytic sample appropriate and described clearly and in 
adequate detail? 
1 
Criterion 4.5: Does the study discuss limitations of the sample and/or sampling 
procedure? 
1 
5. Analysis Methods  
Criterion 5.1: Are the analysis methods clearly described, appropriate for the 
research questions, sufficiently rigorous, and correctly executed? 
1 
Criterion 5.2: Does the report clearly explain and justify key analysis decisions? 1 
Criterion 5.3: Are appropriate statistical procedures used? 1 
Criterion 5.4: Are limitations of the analytic methods discussed, especially those 
that could lead to bias? 
1 
6. Findings and Conclusions  
Criterion 6.1: Are findings fully supported by the data and analysis? 0 
Criterion 6.2: Are conclusions supported by the findings? 1 
Quality score: 95% 
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Critically Appraised Paper #5 
CAP created by Leah Murray 
 
Moxon-Emre, I., Taylor, M. D., Bouffet, E., Hardy, K., Campen, C. J., Malkin, D., … Mabbott, D. J. (2016). Intellectual 
outcome in molecular subgroups of medulloblastoma. Journal of Clinical Oncology, 34(34), 4161–4170. 
https://doi:10.1200/jco.2016.66.9077 
Purpose of the Study • “To compare the rate of change in intellectual functioning between patients in each subgroup 
while controlling for relevant medical and/or demographic features” (Moxon-Emre, et al., 
2016, p. 4162). 
• “To evaluate the impact of treatment with different radiation intensity protocols on 
intellectual outcome within medulloblastoma subgroups” (Moxon-Emre, et al., 2016, p. 4162). 
Setting Hospital 
Participants or Sample • 121 participants with medulloblastoma (Group 4, n = 51; Group 3, n = 25; SHH, n = 28; 
WNT, n = 17) (p.4162) 
• Group 3 and 4 had more males 
• WNT and SHH had relatively equal proportions of male and females  
Study Design and 
Methodology 
• Cohort Study 
• Intellectual paths were compared between the four subgroups 
• The effect of treatment with reduced-dose CSI + TB boost (least-intensive radiation protocol) 
versus treatments that deliver higher CSI doses and/or larger boost volumes to the brain within 
subgroups, were evaluated by controlling for relevant medical and/or demographic features.  
• When completing the subgroup comparison, motor deficits were not included. To determine 
the stability or change in IQ scores over time in the subgroups and radiation intensity, linear 
mixed modeling was used.  
• The scores were evaluated as a function of treatment with either reduced-dose CSI + TB boost 
or all other treatments and IQ test versions were controlled for in all analyses. 
Level of Evidence Level II 
Outcomes and Main Findings • Sex, cerebellar mutism, motor deficits, CSI, chemotherapy, and age at diagnosis differed 
among subgroups. In each subgroup, intellectual outcomes declined similarly except for 
processing speed.  
• SHH had the lowest incidence of cerebellar mutism and motor deficits, showing evidence of 
better functional outcomes and a unique processing speed trajectory declined less than Group 3 
(p. 4169). 
• Reduced-dose CSI + TB (tumor bed) boost treatment was associated with preserved 
intellectual functioning in WNT (wingless) and Group 4 patients but not in Group 3 or SHH 
(p.4169). 
• There were statistical significances in sex, cerebellar mutism, motor deficits, CSI, 
chemotherapy, and age at diagnosis; however, there was not a statistical significance in IQ test 
versions for any measure of intellectual functioning. The outcomes were both valid and 
reliable. 
• To capture fundamental differences in intellectual outcomes between subgroups, the medical 
and demographic features that can influence intellectual outcome must be accounted for. 
• Covariates include sex, age at diagnosis, mutism, CSI treatment, hydrocephalus requiring CSF 
diversion, chemotherapy treatment, and IQ test version are associated with poorer cognitive 
outcome in patients with medulloblastoma. 
• Cerebellar mutism and treated hydrocephalus were significant covariates across all measures 
of intellectual functioning and appear to influence all measures of intellectual functioning and 
age at diagnosis was a significant covariate for processing speed and verbal comprehension 
only.  
• IQ test version was a significant covariate for Full Scale IQ and processing speed and working 
memory only. 
• WNT and Group 4 appear to be the only groups that can benefit from limiting radiation 
exposure.  
Intervention Highlighted N/A 
 
Limitations • Radiation intensity analyses should be evaluated with caution due to small sample sizes. 
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• Group 4 and WNT patients were combined for the radiation intensity analysis due to sample 
size constraints  
• SHH and Group 3 radiation intensity models were random intercept only 
• Patients treated with reduced-dose CSI + TB boost were treated more recently and that may 
have influenced their intellectual outcomes. 
• The participants were treated on different protocols and received various chemotherapy 
agents. 
• Several different IQ test versions were used. 
This Study Was Identified as 
the “Best” Evidence and 
Selected for the Portfolio for 
the Following Reasons: 
This data supports our PICO question by analyzing and comparing the 4 different subgroups of 
medulloblastoma to the radiation intensity used to treat those subgroups, highlighting the long-
term effect that has on intellectual functioning in survivors of medulloblastoma. 
Quality Score: 77% 
  
1. Study Design 
 
 
Criterion 1.1: Is the study design clear and appropriate for addressing the research 
questions? 
1 
Criterion 1.2: Are the program(s) or conditions applying to the group(s) of interest 
clearly described in sufficient detail to understand and replicate? 
1 
Criterion 1.3: Are key features of the design—including time, place, and context 
clearly described? This includes the sampling design, if applicable.  
 
0 
Criterion 1.4: Does the study explain limitations of the design and draw 
appropriate implications for interpreting findings? 
1 
2. Data Quality 
 
 
Criterion 2.1: Are data sources clearly identified and appropriate for addressing the 
research questions? 
1 
Criterion 2.2: Do key variables and/or outcome measures have face validity and 
does the study discuss their reliability and validity? 
 
1 
Criterion 2.3: Are issues of data completeness, consistency, and accuracy, as well 
as steps researchers took to resolve these issues, addressed clearly, in sufficient 
detail, and appropriately? 
 
0 
Criterion 2.4: Is the description of study-designed variables clear and do study-
designed variables make sense given the outcome of interest for the research 
question? 
1 
3. Data Collection  
Criterion 3.1: Are the data collection methods, sources, and instruments clearly 
described and appropriate for the research questions? 
1 
Criterion 3.2: Does data collection reflect sound and systematic methods to 
produce reliable data? 
0 
Criterion 3.3: Does data collection reflect methods that produce unbiased results? 1 
4. Study Sample  
Criterion 4.1: Does the study examine a population relevant to the research 
questions? 
1 
Criterion 4.2: Is the sampling design clearly defined and defensible? 1 
Criterion 4.3: Are inclusion and/or exclusion restrictions clear and defensible? 1 
Criterion 4.4: Is the analytic sample appropriate and described clearly and in 
adequate detail? 
1 
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Criterion 4.5: Does the study discuss limitations of the sample and/or sampling 
procedure? 
1 
5. Analysis Methods  
Criterion 5.1: Are the analysis methods clearly described, appropriate for the 
research questions, sufficiently rigorous, and correctly executed? 
1 
Criterion 5.2: Does the report clearly explain and justify key analysis decisions? 0 
Criterion 5.3: Are appropriate statistical procedures used? 1 
Criterion 5.4: Are limitations of the analytic methods discussed, especially those 
that could lead to bias? 
0 
6. Findings and Conclusions  
Criterion 6.1: Are findings fully supported by the data and analysis? 1 
Criterion 6.2: Are conclusions supported by the findings? 1 
Quality score: 77% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CRITICALLY APPRAISED TOPIC 
 
21 
Critically Appraised Paper #6 
CAP completed by Leah Murray 
 
Brinkman, T., Ness, K., Li, Z., Huang, I-C., Krull, K., Gajjar, A., Merchant, T., … Armstrong, G. (2016). Qos-30 Functional 
 independence in adult survivors of pediatric CNS tumors: A report from the St. Jude Lifetime Cohort Study. Journal of 
Clinical Oncology, 36(27) 2762-2769. https://doi:10.1093/neuonc/now081.30 
Purpose of the Study • “To provide a comprehensive assessment of independence in survivors of CNS tumors by 
identifying profiles of functional and social independence using multiple concurrent indicators, 
examining the contribution of physical performance status to failure to achieve independence, 
and assessing the effect on survivors’ health-related quality of life” (Brinkman, et al., 2016, p. 
2763). 
Setting St. Jude Children’s Research Hospital  
Participants or Sample • 306 adult survivors of childhood CNS tumors who completed baseline evaluations as part of 
the St. Jude Lifetime Cohort Study. 
• On average 26.3 years of age and 17.6 years since original diagnosis 
• Currently ≥18 years of age 
• ≥10 years since their original diagnosis 
• “Survivors were excluded if they had a neurologic disorder or injury unrelated to their primary 
cancer diagnosis or its treatment and known to affect functional independence.  
• “Approximately one-third of participants received focal irradiation and one-third craniospinal 
irradiation” (p. 2763). 
• Covariates included physical health status and intelligence. 
Study Design and 
Methodology 
• Cohort study 
• Six indicators were observed to identify independence which included employment, living 
independently, assistance with personal care, assistance with routine needs, obtaining a driver’s 
license, and marital status.  
• HRQOL (Health-related quality of life) was assessed and provided two composite scores 
(general health and mental) and subscale scores for eight domains (general health, role physical, 
physical function, bodily pain, vitality, mental health, social function, and role emotion).  
• Psychological distress was measured with the Brief Symptom Inventory 18 providing an 
overall index of global psychological distress as well as anxiety, depression, and somatization 
subscales. 
Level of Evidence Level II 
Outcomes and Main Findings • Functional independence was identified as independent, moderately independent, and non-
independent.  
• Craniospinal irradiation (CSI) and younger age at diagnosis were associated with risk of non-
independence versus independence. 
• Multivariable models considered limitations in aerobic capacity, leg strength, flexibility, and 
adaptive physical function were associated with an increased risk of non-independence.  
• Survivors who were non-independent were more likely to have severe impairment in attention, 
memory, and executive functioning, and reported reduced physical but not mental health related 
quality of life compared with independent survivors. 
• The results were statistically significant, valid, reliable, and 95% CIs were calculated. 
• The current results suggest that for this identified group of non-independent survivors of CNS 
tumors, multimodal interventions that target both cognitive and physical performance deficits 
are warranted. 
• The goal should be to deliver therapies that maximize both survivors and opportunities for 
functional and social independence throughout the lifespan. 
Intervention Highlighted 
Through the Research 
N/A 
Limitations • A larger proportion of survivors of medulloblastoma were participants than nonparticipants 
• Future research is needed to understand the longitudinal trajectory of independence in 
survivors as well as the effect of changes in front-line therapies on degrees of independence. 
• “Future research should include the use of validated measures of independence and disability 
because normative population data may provide additional information about the magnitude of 
risk of non-independence among survivors” (p. 2768) 
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This Study Was Identified as 
the “Best” Evidence and 
Selected for the Portfolio for 
the Following Reasons: 
This data supports our PICO question by capitalizing on the independence of survivors as 
adults. The results are beneficial in helping us better understand the dynamics of treatment for 
medulloblastoma and its impact on function. 
Quality Score: 77% 
  
1. Study Design 
 
 
Criterion 1.1: Is the study design clear and appropriate for addressing the research 
questions? 
1 
Criterion 1.2: Are the program(s) or conditions applying to the group(s) of interest 
clearly described in sufficient detail to understand and replicate? 
1 
Criterion 1.3: Are key features of the design—including time, place, and context 
clearly described? This includes the sampling design, if applicable.  
 
0 
Criterion 1.4: Does the study explain limitations of the design and draw 
appropriate implications for interpreting findings? 
1 
2. Data Quality 
 
 
Criterion 2.1: Are data sources clearly identified and appropriate for addressing the 
research questions? 
1 
Criterion 2.2: Do key variables and/or outcome measures have face validity and 
does the study discuss their reliability and validity? 
 
0 
Criterion 2.3: Are issues of data completeness, consistency, and accuracy, as well 
as steps researchers took to resolve these issues, addressed clearly, in sufficient 
detail, and appropriately? 
 
1 
Criterion 2.4: Is the description of study-designed variables clear and do study-
designed variables make sense given the outcome of interest for the research 
question? 
1 
3. Data Collection  
Criterion 3.1: Are the data collection methods, sources, and instruments clearly 
described and appropriate for the research questions? 
0 
Criterion 3.2: Does data collection reflect sound and systematic methods to 
produce reliable data? 
0 
Criterion 3.3: Does data collection reflect methods that produce unbiased results? 0 
4. Study Sample  
Criterion 4.1: Does the study examine a population relevant to the research 
questions? 
1 
Criterion 4.2: Is the sampling design clearly defined and defensible? 1 
Criterion 4.3: Are inclusion and/or exclusion restrictions clear and defensible? 1 
Criterion 4.4: Is the analytic sample appropriate and described clearly and in 
adequate detail? 
1 
Criterion 4.5: Does the study discuss limitations of the sample and/or sampling 
procedure? 
 
1 
5. Analysis Methods  
Criterion 5.1: Are the analysis methods clearly described, appropriate for the 
research questions, sufficiently rigorous, and correctly executed? 
 
1 
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Criterion 5.2: Does the report clearly explain and justify key analysis decisions? 1 
Criterion 5.3: Are appropriate statistical procedures used? 1 
Criterion 5.4: Are limitations of the analytic methods discussed, especially those 
that could lead to bias? 
1 
6. Findings and Conclusions  
Criterion 6.1: Are findings fully supported by the data and analysis? 1 
Criterion 6.2: Are conclusions supported by the findings? 1 
Quality score: 77% 
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Appendix B 
Modified PRISMA Form 
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Appendix C 
Goal Attainment Scale  
                    
 
                              
                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                      *Note: Vertical Axis=GAS Score; Horizontal Axis=Date/Time 
 
 
 
 
